Advertisement
Review Article|Articles in Press

Oral Lesions Associated with Systemic Disease

Published:February 15, 2023DOI:https://doi.org/10.1016/j.coms.2022.10.002

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Oral and Maxillofacial Surgery Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schenkein H.A.
        • Papapanou P.N.
        • Genco R.
        • et al.
        Mechanisms underlying the association between periodontitis and atherosclerotic disease.
        Periodontol 2000. 2020; 83: 90-106
        • Del Pinto R.
        • Pietropaoli D.
        • Munoz-Aguilera E.
        • et al.
        Periodontitis and Hypertension: Is the Association Causal?.
        High Blood Press Cardiovasc Prev. 2020; 27: 281-289
        • Chapple I.L.
        • Genco R.
        Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.
        J Periodontol. 2013; 84: S106-S112
        • Hazenberg B.P.
        Amyloidosis: a clinical overview.
        Rheum Dis Clin North Am. 2013; 39: 323-345
        • Penner C.R.
        • Muller S.
        Head and neck amyloidosis: a clinicopathologic study of 15 cases.
        Oral Oncol. 2006; 42: 421-429
        • Elad S.
        • Czerninski R.
        • Fischman S.
        • et al.
        Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
        Amyloid. 2010; 17: 27-31
        • Thompson L.D.
        • Derringer G.A.
        • Wenig B.M.
        Amyloidosis of the larynx: a clinicopathologic study of 11 cases.
        Mod Pathol. 2000; 13: 528-535
        • Neville B.W.
        • Damm D.D.
        • Allen C.M.
        • et al.
        Oral manifestations of systemic diseases.
        in: Oral and maxillofacial pathology. 4th edition. Elsevier, St Louis (MO)2016: 751-800
        • Deng J.
        • Chen Q.
        • Ji P.
        • et al.
        Oral amyloidosis: A strategy to differentiate systemic amyloidosis involving the oral cavity and localized amyloidosis.
        Oral Dis. 2019; 25: 670-675
        • Frenkel B.
        • Vered M.
        • Taicher S.
        • et al.
        Lipoid proteinosis unveiled by oral mucosal lesions: a comprehensive analysis of 137 cases.
        Clin Oral Investig. 2017; 21: 2245-2251
        • Dertlioglu S.B.
        • Calik M.
        • Cicek D.
        Demographic, clinical, and radiologic signs and treatment responses of lipoid proteinosis patients: a 10-case series from Sanliurfa.
        Int J Dermatol. 2014; 53: 516-523
        • Lee K.C.
        • Peters S.M.
        • Ko Y.C.K.
        • et al.
        Oral manifestations of lipoid proteinosis in a 10-year-old female: A case report and literature update.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 126: e228-e232
        • Koen N.
        • Fourie J.
        • Terburg D.
        • et al.
        Translational neuroscience of basolateral amygdala lesions: Studies of Urbach-Wiethe disease.
        J Neurosci Res. 2016; 94: 504-512
        • Deshpande P.
        • Guledgud M.V.
        • Patil K.
        • et al.
        Lipoid proteinosis: a rare encounter in dental office.
        Case Rep Dent. 2015; 2015: 670369
        • Ozkaya-Bayazit E.
        • Ozarmagan G.
        • Baykal C.
        • et al.
        [Oral DMSO therapy in 3 patients with lipoidproteinosis. results of long-term therapy].
        Hautarzt. 1997; 48: 477-481
        • Zhang R.
        • Liu Y.
        • Xue Y.
        • et al.
        Treatment of lipoid proteinosis due to the p.C220G mutation in ECM1, a major allele in Chinese patients.
        J Transl Med. 2014; 12: 85
        • Chan S.W.
        • Scully C.
        • Prime S.S.
        • et al.
        Pyostomatitis vegetans: oral manifestation of ulcerative colitis.
        Oral Surg Oral Med Oral Pathol. Dec 1991; 72: 689-692
        • Hegarty A.M.
        • Barrett A.W.
        • Scully C.
        Pyostomatitis vegetans.
        Clin Exp Dermatol. 2004; 29: 1-7
        • Pazheri F.
        • Alkhouri N.
        • Radhakrishnan K.
        Pyostomatitis vegetans as an oral manifestation of Crohn's disease in a pediatric patient.
        Inflamm Bowel Dis. 2010; 16: 2007
        • Atarbashi-Moghadam S.
        • Lotfi A.
        • Atarbashi-Moghadam F.
        Pyostomatitis vegetans: a clue for diagnosis of silent crohn's disease.
        J Clin Diagn Res. 2016; 10: ZD12-ZD13
        • Ficarra G.
        • Cicchi P.
        • Amorosi A.
        • et al.
        Oral Crohn's disease and pyostomatitis vegetans. an unusual association.
        Oral Surg Oral Med Oral Pathol. 1993; 75: 220-224
        • Lv R.
        • Qiao W.
        • Wu Z.
        • et al.
        Tumor necrosis factor alpha blocking agents as treatment for ulcerative colitis intolerant or refractory to conventional medical therapy: a meta-analysis.
        PLoS One. 2014; 9: e86692
        • Fiorino G.
        • D'Amico F.
        • Italia A.
        • et al.
        JAK inhibitors: Novel developments in management of ulcerative colitis.
        Best Pract Res Clin Gastroenterol. 2018; 32-33: 89-93
        • Alrashdan M.S.
        • Safadi R.A.
        Crohn's disease initially presenting with oral manifestations and managed with ustekinumab: A case report.
        Spec Care Dentist. 2021; 41: 634-638
        • Woo V.L.
        Oral Manifestations of crohn's disease: a case report and review of the literature.
        Case Rep Dent. 2015; 2015: 830472
        • Tan C.X.
        • Brand H.S.
        • de Boer N.K.
        • et al.
        Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn's disease.
        Br Dent J. 2016; 221: 794-799
        • Aguirre A.
        • Nugent C.A.
        Images in clinical medicine: oral manifestation of crohn's disease.
        N Engl J Med. 2015; 373: 1250
        • Grossi S.G.
        Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research.
        Ann Periodontol. 2001; 6: 138-145
        • Darre L.
        • Vergnes J.N.
        • Gourdy P.
        • et al.
        Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies.
        Diabetes Metab. 2008; 34: 497-506
        • Moore P.A.
        • Weyant R.J.
        • Mongelluzzo M.B.
        • et al.
        Type 1 diabetes mellitus and oral health: assessment of periodontal disease.
        J Periodontol. 1999; 70: 409-417
        • Islam N.M.
        • Bhattacharyya I.
        • Cohen D.M.
        Common oral manifestations of systemic disease.
        Otolaryngol Clin North Am. 2011; 44 (vi): 161-182
        • Thorstensson H.
        • Kuylenstierna J.
        • Hugoson A.
        Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics.
        J Clin Periodontol. 1996; 23: 194-202
        • Camaschella C.
        Iron-deficiency anemia.
        N Engl J Med. 2015; 372: 1832-1843
        • Wu Y.C.
        • Wang Y.P.
        • Chang J.Y.
        • et al.
        Oral manifestations and blood profile in patients with iron deficiency anemia.
        J Formos Med Assoc. 2014; 113: 83-87
        • Deane S.
        • Schroth R.J.
        • Sharma A.
        • et al.
        Combined deficiencies of 25-hydroxyvitamin D and anemia in preschool children with severe early childhood caries: a case-control study.
        Paediatr Child Health. 2018; 23: e40-e45
        • Andres E.
        • Serraj K.
        Optimal management of pernicious anemia.
        J Blood Med. 2012; 3: 97-103
        • Toh B.H.
        Pathophysiology and laboratory diagnosis of pernicious anemia.
        Immunol Res. 2017; 65: 326-330
        • Mohamed M.
        • Thio J.
        • Thomas R.S.
        • et al.
        Pernicious anaemia.
        BMJ. 2020; 369: m1319
        • Goonewardene M.
        • Shehata M.
        • Hamad A.
        Anaemia in pregnancy.
        Best Pract Res Clin Obstet Gynaecol. 2012; 26: 3-24
        • Kuipers E.J.
        Pernicious anemia, atrophic gastritis, and the risk of cancer.
        Clin Gastroenterol Hepatol. 2015; 13: 2290-2292
        • Nishida M.
        • Grossi S.G.
        • Dunford R.G.
        • et al.
        Dietary vitamin C and the risk for periodontal disease.
        J Periodontol. 2000; 71: 1215-1223
        • Fontana M.
        Vitamin C (ascorbic acid): clinical implications for oral health--a literature review.
        Compendium. 1994; 15 (920 passim; quiz 930): 916-918
        • Kitcharoensakkul M.
        • Schulz C.G.
        • Kassel R.
        • et al.
        Scurvy revealed by difficulty walking: three cases in young children.
        J Clin Rheumatol. 2014; 20: 224-228
        • Halligan T.J.
        • Russell N.G.
        • Dunn W.J.
        • et al.
        Identification and treatment of scurvy: a case report.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100: 688-692